NXGL · Nexgel Inc
United States · RS rating 20 · As of 2026-11-03
| Price | 4.48 USD |
|---|---|
| 1-day change | +18.2% |
| RS rating (overall / 1M / 3M / 12M) | 20 / 97 / 11 / 5 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 19 / 11 / 18 |
| Industry group (rank) | Medical-Ethical Drugs (94) |
| EPS growth Q/Q | -263.6% |
| Sales growth Q/Q | -4.7% |
| Distance from 52-week high | +91.0% |
| Market cap (USD) | $5.2M |